UBS’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$7K Sell
542
-5,994
-92% -$77.4K ﹤0.01% 5976
2014
Q2
$148K Buy
+6,536
New +$148K ﹤0.01% 3926